JP Stock MarketDetailed Quotes

8316 Sumitomo Mitsui Financial Group

Watchlist

3912.0
+35.0+0.90%

20min DelayTrading Feb 18 13:37 JST

15.35TMarket Cap16.20P/E (Static)

Sumitomo Mitsui Financial Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sumitomo Mitsui Financial Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 1.070T	--
--	2025/Q4	-- / 923.965B	--
--	2025/Q3	1.117T / 944.161B	--
Nov 14, 2024	2025/Q2	1.015T / 934.414B	--
Aug 2, 2024	2025/Q1	1.030T / 1.006T	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 1.070T--

--2025/Q4-- / 923.965B--

--2025/Q31.117T / 944.161B--

Nov 14, 20242025/Q21.015T / 934.414B--

Aug 2, 20242025/Q11.030T / 1.006T--

Unlock Free Earnings Estimates

Open Account

Sumitomo Mitsui Financial Group Earnings Reports

Sumitomo Mitsui Financial Group: Status of capital adequacy ratio for the 3rd quarter of the fiscal year ending March 31, 2025

Feb 14 03:00 ET

Sumitomo Mitsui Financial Group: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Jan 29 01:30 ET

Sumitomo Mitsui Financial Group: Submission of the 2024/9 Interim Report on Form 6-K addressed to the U.S. Securities and Exchange Commission

Dec 26, 2024 18:45 ET

Sumitomo Mitsui Financial Group: Confirmation letter

Nov 29, 2024 00:36 ET

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.

Analysis

Analyst Rating

Updated: Feb 14, 2025

Buy

Strong Buy
38.46%
Buy
30.77%
Hold
30.77%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Interest Rate Hike

Intraday+1.28%